Elastography in the Evaluation of Liver Fibrosis
Key Points
Key Points
It can be performed rapidly at bedside in an ambulatory office setting, has a wide range of scores (2.5–75 kPa), is associated with acceptable intra-observer and inter-observer reproducibility, and has been validated in large cohorts worldwide in a spectrum of liver diseases, including hepatitis B, hepatitis C, fatty liver disease, and autoimmune liver disorders, among others.
Diagnosis
...iagnosis
...chronic hepatitis C, the AGA reco...
...nts with chronic hepatitis C, the AG...
...hotic patients with HCV who have achieved A susta...
...ents with chronic hepatitis B, the AGA...
...patients with chronic hepatitis B, the AGA s...
...A makes no recommendation regarding the...
...with chronic alcoholic liver disease, the AGA su...
...ents with suspected compensated cirr...
...ts with suspected chronic liver dis...
...patients with chronic hepatitis C, the AGA sugg...
...s with NAFLD and a higher risk of cirrh...
...AFLD and a lower risk of cirrhosis, AGA makes no...
Suggested VCTE Cutoffs
...ed VCTE Cutoffs Condition VCTE...